Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — Financial Flexibility Index
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of $133.50 Million (operating CF $118.45 Million minus capex $15.05 Million) represents 0% of total liabilities ($2.78 Billion). Check total reinvestment intensity of Amneal Pharmaceuticals, Inc. Class A Com to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Amneal Pharmaceuticals, Inc. Class A Common Stock Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Amneal Pharmaceuticals, Inc. Class A Common Stock across 10 annual periods. For the full cash flow conversion analysis, see how efficiently does Amneal Pharmaceuticals, Inc. Class A Com generate cash.
Annual Financial Flexibility Index for Amneal Pharmaceuticals, Inc. Class A Common Stock (2015–2024)
Year-by-year free cash flow to debt coverage for Amneal Pharmaceuticals, Inc. Class A Common Stock. Explore AMRX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.10x | $347.02 Million | $295.10 Million | $3.55 Billion | ▼ -18.5% |
| 2023 | 0.12x | $414.77 Million | $345.58 Million | $3.45 Billion | ▲ +177.0% |
| 2022 | 0.04x | $155.69 Million | $65.10 Million | $3.59 Billion | ▼ -47.4% |
| 2021 | 0.08x | $294.46 Million | $241.82 Million | $3.57 Billion | ▼ -32.2% |
| 2020 | 0.12x | $445.19 Million | $379.00 Million | $3.66 Billion | ▲ +307.1% |
| 2019 | 0.03x | $99.14 Million | $1.71 Million | $3.32 Billion | ▼ -70.3% |
| 2018 | 0.10x | $347.32 Million | $250.23 Million | $3.46 Billion | ▼ -50.5% |
| 2017 | 0.20x | $348.46 Million | $234.19 Million | $1.72 Billion | ▲ +18.1% |
| 2016 | 0.17x | $239.67 Million | $115.06 Million | $1.39 Billion | ▼ -7.2% |
| 2015 | 0.19x | $222.26 Million | $104.88 Million | $1.20 Billion | — |